Series de enfermedades infecciosas. Actualizaciones sobre enfermedad infecciosa neumocócica

Lecturas recomendadas

  • The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect. 2018 Nov;77(5):368-378. 
  • Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study. Vaccine. 2019 Apr 10;37(16):2200-2207. 
  • Prevalence of Immunodeficiency in Children With Invasive Pneumococcal Disease in the Pneumococcal Vaccine Era: A Systematic Review. JAMA Pediatr. 2019 Nov 1;173(11):1084-1094.
  • Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain. Emerg Infect Dis. 2020 Jun;26(6):1147-1155. 
  • Impact of Pneumococcal Vaccination in the Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children of the Murcia Region in Spain. Vaccines (Basel). 2020 Dec 28;9(1):14.
  • Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine. An Pediatr (Engl Ed). 2021 Jul 6;S2341-2879(21)00113-7.
  • Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children. Emerg Infect Dis. 2021;27(6):1627-1636.
     
  • Arias-Fernández L, San-Román Montero J, Gil-Prieto R, Walter S, Gil de Miguel Á. Burden of pneumonia in patients with viral and bacterial coinfection in Spain during six consecutive influenza seasons, from 2009-10 to 2014-15. Vaccine. 2021 Aug 16;39(35):5002-5006. doi: 10.1016/j.vaccine.2021.07.035.
  • De Miguel S, Domenech M, González-Camacho F, Sempere J, Vicioso D, Sanz JC, García Comas L, Ardanuy C, Fenoll A, Yuste J. Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era. Clin Infect Dis. 2020 Sep 29:ciaa1483. doi: 10.1093/cid/ciaa1483.
  • Pick H, Daniel P, Rodrigo C, Bewick T, Ashton D, Lawrence H, Baskaran V, Edwards-Pritchard RC, Sheppard C, Eletu SD, Rose S, Litt D, Fry NK, Ladhani S, Chand M, Trotter C, McKeever TM, Lim WS. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18. Thorax. 2020 Jan;75(1):38-49. doi: 10.1136/thoraxjnl-2019-213725. 
  • Weinberger DM, Warren JL, Dalby T, Shapiro ED, Valentiner-Branth P, Slotved HC, Harboe ZB. Differences in the Impact of Pneumococcal Serotype Replacement in Individuals With and Without Underlying Medical Conditions. Clin Infect Dis. 2019 Jun 18;69(1):100-106. doi: 10.1093/cid/ciy875.
  • Naucler, P.; Galanis, I.; Petropoulos, A.; Granath, F.; Morfeldt, E.; Örtqvist, Å.; Henriques-Normark, B. Chronic disease and immunosuppression increase the risk for non-vaccine serotype pneumococcal disease—A nationwide population-based study. Clin. Infect. Dis. 2021
  • Hanquet G, Krizova P, Valentiner-Branth P, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax 2019; 74(5): 473-82.
  • Shen L, Jhund PS, Anand IS, Bhatt AS, Desai AS, Maggioni AP, Martinez FA, Pfeffer MA, Rizkala AR, Rouleau JL, Swedberg K, Vaduganathan M, Vardeny O, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Solomon SD, McMurray JJV. Incidence and Outcomes of Pneumonia in Patients With Heart Failure. J Am Coll Cardiol. 2021 Apr 27;77(16):1961-1973. doi: 10.1016/j.jacc.2021.03.001.
  • Aldás I, Menéndez R, Méndez R, España PP, Almirall J, Boderías L, Rajas O, Zalacaín R, Vendrell M, Mir I, Torres A; Grupo NEUMONAC; Anexo. Grupo NEUMONAC. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia. Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):551-558. English, Spanish. doi: 10.1016/j.arbres.2019
  • Menendez R, Mendez R, Aldas I, et al. Community-acquired pneumonia patients at risk for early and long-term cardiovascular events are identified by cardiac biomarkers. Chest 2019; 156:1080–91.
  • Cilli A, Cakin O, Aksoy E, et al. Acute cardiac events in severe community acquired pneumonia: a multicenter study. Clin Respir J 2018; 12:2212–9.
  • Ciruela P, Broner S, Izquierdo C, Pallarés R, Muñoz-Almagro C, Hernández S, Grau I, Domínguez A, Jané M; Catalan Working Group on Invasive Pneumococcal Disease. Indirect effects of paediatric conjugate vaccines on invasive pneumococcal disease in older adults. Int J Infect Dis. 2019 Sep;86:122-130. doi: 10.1016/j.ijid.2019.06.030
  • Aliberti S, Cook GS, Babu BL, et al; GLIMP investigators. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. J Infect 2019; 79:300–11.
  • Yahiaoui RY, Bootsma HJ, den Heijer CDJ, et al. Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries. BMC Infect Dis 2018; 18:440.
  • Troeger, C.; Blacker, B.; Khalil, I.A.; Rao, P.C.; Cao, J.; Zimsen, S.R.M.; Albertson, S.B.; Deshpande, A.; Farag, T.; Abebe, Z.; et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 2018, 18, 1191–1210.
     

Para cualquier consulta o incidencia contacte con faqs@cmep-infectious.com

Curso acreditado con 5,9 créditos de formación continuada para la profesión de medicina.

© 2025

Logo International Marketing & Communication
Aviso legal Política de Privacidad